Newly Approved Drug Therapies (387): Photofrin, QLT

Description of Medical Areas

About the FDA Approved Listings

Drugs Approved by the FDA

Drug Name: Photofrin

The following information is obtained from various newswires, published medical journal articles, and medical conference presentations.

Company: QLT
Approval Status: Approved January 1998
Treatment for: Non-small cell lung cancer

General Information

QLT PhotoTherapeutics' light-activated drug Photofrin (porfimer sodium) was approved for injection in treating early-stage, microinvasive lung cancer. It is approved for use in patients with microinvasive endobronchial non-small cell lung cancer at an early stage, for whom surgery and radiotherapy are not indicated.

Back to Drug Listing

Drug listing last updated on June 20, 2008

Patient Resources: [ Trial Listing ] [ Notification Services ] [ Drug Directories ]
[ About Clinical Research ] [ Patient Resources ] [ Patient Bookstore ]
Professional Resources: [ Research Center Profiles ] [ Industry Provider Profiles ] [ Jobs in Clinical Research ]
[ Industry News ] [ Professional Resources ] [ Professional Bookstore ]
General: [ Search ] [ Site Map ] [ Your Privacy ] [ CW World ] [ Home ]